Showing results (521-530 of 847) with videos related to

Sort By:
Pageof 85
JNCI Cancer Spectrum|August 11, 2021
Penetrance of Breast Cancer Susceptibility Genes From the eMERGE III NetworkXiao Fan, Julia Wynn, Ning Shang, et al.
JNCI Cancer Spectrum|August 11, 2021
Association Between Smoking and Molecular Subtypes of Colorectal CancerXiaoliang Wang, Efrat Amitay, Tabitha A Harrison, et al.
JNCI Cancer Spectrum|August 5, 2021
Moving Forward in the Next Decade: Radiation Oncology Sciences for Patient-Centered Cancer CareC Norman Coleman, Jeffrey C Buchsbaum, Pataje G S Prasanna, et al.
JNCI Cancer Spectrum|August 5, 2021
Decision Science Can Inform Clinical Trade-Offs Regarding Cardiotoxic Cancer TreatmentsArielle S Gillman, Jacqueline B Vo, Anju Nohria, et al.
JNCI Cancer Spectrum|February 16, 2023
Health-care access dimensions and ovarian cancer survival: SEER-Medicare analysis of the ORCHiD studyMary Katherine Montes de Oca, Quan Chen, Elizabeth Howell, et al.
JNCI Cancer Spectrum|November 14, 2025
Pre-diagnosis diabetes, life-course body mass index and physical activity, and pancreatic cancer survival in older adultsNoah C Peeri, Pedro F Saint-Maurice, Hyokyoung G Hong, et al.
JNCI Cancer Spectrum|January 12, 2026
Impact of county financial assistance on cancer treatment and survival among uninsured patientsMuhammad Sohaib Khan, Tammy Leonard, Bella Etingen, et al.
JNCI Cancer Spectrum|January 25, 2026
Comparison of the effects of low- versus High-Supervision exercise on breast cancer survivorship outcomesKira Bloomquist, Rosalind R Spence, Dimitrios Vagenas, et al.
JNCI Cancer Spectrum|January 8, 2026
Bone and soft tissue sarcoma mortality in 19,811 patients diagnosed in Japan, 2006-2020Kengo Kawaguchi, Makoto Endo, Haruhisa Fukuda, et al.
JNCI Cancer Spectrum|December 22, 2025
Assessment tools for Chemotherapy-Induced peripheral neuropathy: a narrative review of clinician, Patient-Reported, and objective measuresKaitlin Chen, Eric Antonen, Michelle B Nadler, et al.
Pageof 85